Prevalence and Severity of Gastrointestinal Symptoms in COVID-19 Patients in Casablanca: A Retrospective Cohort Study.

Autor:	Belabbes FZ; Gastroenterology and Hepatology, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences, Casablanca, MAR., Maizi M; Gastroenterology and Hepatology, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences, Casablanca, MAR., Belghyti N; Pediatrics, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences, Casablanca, MAR., Hmamouchi I; Laboratory of Biostatistics, Clinical Research and Epidemiology, Mohammed V University in Rabat. Morocco., Casablanca, MAR., Khalis M; Epidemiology and Public Health, Mohammed VI University of Health Sciences, Casablanca, MAR., El Aidaoui K; Anesthesia and Critical Care, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences, Casablanca, MAR., Kantri A; Anesthesia and Critical Care, Cheikh Khalifa International University Hospital, Casablanca, MAR., El Kettani C; Anesthesia and Critical Care, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences, Casablanca, MAR., Naitlhou A; Internal Medicine, Cheikh Khalifa International University Hospital, Mohammed VI University of Health Sciences, Casablanca, MAR., Rouibaa F; Gastroenterology and Hepatology, Cheikh Khalifa International University Hospital, Faculty of Medicine, Mohammed VI University of Health Sciences, Casablanca, MAR.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2022 Aug 09; Vol. 14 (8), pp. e27815. Date of Electronic Publication: 2022 Aug 09 (Print Publication: 2022).
DOI:	10.7759/cureus.27815
Abstrakt:	Background The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the coronavirus disease 2019 (COVID-19), is behind the current pandemic. At the start of the pandemic, gastrointestinal symptoms initially described as rare were reported, but their spread to other countries increased rapidly. This study aimed to determine the prevalence of digestive symptoms among COVID-19 patients and to assess the correlation between these symptoms and disease severity. Methods This retrospective observational study was conducted in the Cheikh Khalifa University Hospital of Casablanca, Morocco. Patients were divided into two groups based on the presence or absence of gastrointestinal symptoms upon initial assessment and hospital admission. Results A total of 154 patients were included in this study from March 21 to April 26, 2020. The mean age of patients was about 48.5 (± 20.0) years, and 85 (55.2%) of them were men. In our population, 8.17% of patients had toxic habits. Digestive symptoms were present at admission in 30% of our patients. The most frequent digestive symptoms were diarrhea (15%), abdominal pain (5.6%), vomiting (5%), and anorexia (3.1%). We found a significant difference in COVID-19 patients with digestive symptoms and toxic habits contrary to all other comorbidities. Neurologic symptoms were significantly associated (p=0,004) with digestive symptoms in 50%. Conclusion In this study, we found that digestive symptoms were present in 22.64% of patients diagnosed with COVID-9. The clinician must know the different digestive symptoms to evoke the diagnosis and take charge of the patient early. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Belabbes et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu